Cargando…

Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in non‐small cell lung cancer patients after surgery

BACKGROUND: There are no validated and reliable cough‐specific instruments to assess health‐related quality of life with respect to postoperative cough in non‐small cell lung cancer (NSCLC) patients. We used the Leicester Cough Questionnaire in Mandarin‐Chinese (LCQ‐MC) and investigated the validity...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Rongjia, Che, Guowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879047/
https://www.ncbi.nlm.nih.gov/pubmed/29484851
http://dx.doi.org/10.1111/1759-7714.12602
_version_ 1783310924547883008
author Lin, Rongjia
Che, Guowei
author_facet Lin, Rongjia
Che, Guowei
author_sort Lin, Rongjia
collection PubMed
description BACKGROUND: There are no validated and reliable cough‐specific instruments to assess health‐related quality of life with respect to postoperative cough in non‐small cell lung cancer (NSCLC) patients. We used the Leicester Cough Questionnaire in Mandarin‐Chinese (LCQ‐MC) and investigated the validity, reliability, and repeatability of this instrument. METHODS: A total of 130 NSCLC patients (average age 58.75 ± 9.43 years, 65 men, 65 women) completed the LCQ‐MC, cough Visual Analogue Scale (VAS), Cough Symptom Score (CSS), Hospital Anxiety and Depression Scale (HADS), and Medical Outcomes Study 36‐item Short‐Form Health Survey (SF‐36). Forty patients completed the LCQ‐MC again one week later. Concurrent validity, internal consistency, and repeatability were assessed. RESULTS: Analyses of concurrent validity showed significant correlations between the LCQ‐MC and the cough VAS (r = −0.488 to −0.660) and CSS (r = −0.495 to −0.601). The corresponding domains of the LCQ‐MC and the SF‐36 exhibited moderate correlations (r = 0.421–0.432). However, there was no significant correlation between the LCQ‐MC and the HADS (P > 0.05). Internal consistency was acceptable (Cronbach's α of 0.74–0.90). Test‐retest reliability was high (intraclass correlation coefficients of 0.89–0.95). CONCLUSION: The LCQ‐MC is a reliable, valid instrument for assessing postoperative cough in NSCLC patients.
format Online
Article
Text
id pubmed-5879047
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-58790472018-04-04 Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in non‐small cell lung cancer patients after surgery Lin, Rongjia Che, Guowei Thorac Cancer Original Articles BACKGROUND: There are no validated and reliable cough‐specific instruments to assess health‐related quality of life with respect to postoperative cough in non‐small cell lung cancer (NSCLC) patients. We used the Leicester Cough Questionnaire in Mandarin‐Chinese (LCQ‐MC) and investigated the validity, reliability, and repeatability of this instrument. METHODS: A total of 130 NSCLC patients (average age 58.75 ± 9.43 years, 65 men, 65 women) completed the LCQ‐MC, cough Visual Analogue Scale (VAS), Cough Symptom Score (CSS), Hospital Anxiety and Depression Scale (HADS), and Medical Outcomes Study 36‐item Short‐Form Health Survey (SF‐36). Forty patients completed the LCQ‐MC again one week later. Concurrent validity, internal consistency, and repeatability were assessed. RESULTS: Analyses of concurrent validity showed significant correlations between the LCQ‐MC and the cough VAS (r = −0.488 to −0.660) and CSS (r = −0.495 to −0.601). The corresponding domains of the LCQ‐MC and the SF‐36 exhibited moderate correlations (r = 0.421–0.432). However, there was no significant correlation between the LCQ‐MC and the HADS (P > 0.05). Internal consistency was acceptable (Cronbach's α of 0.74–0.90). Test‐retest reliability was high (intraclass correlation coefficients of 0.89–0.95). CONCLUSION: The LCQ‐MC is a reliable, valid instrument for assessing postoperative cough in NSCLC patients. John Wiley & Sons Australia, Ltd 2018-02-27 2018-04 /pmc/articles/PMC5879047/ /pubmed/29484851 http://dx.doi.org/10.1111/1759-7714.12602 Text en © 2018 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Lin, Rongjia
Che, Guowei
Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in non‐small cell lung cancer patients after surgery
title Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in non‐small cell lung cancer patients after surgery
title_full Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in non‐small cell lung cancer patients after surgery
title_fullStr Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in non‐small cell lung cancer patients after surgery
title_full_unstemmed Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in non‐small cell lung cancer patients after surgery
title_short Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in non‐small cell lung cancer patients after surgery
title_sort validation of the mandarin chinese version of the leicester cough questionnaire in non‐small cell lung cancer patients after surgery
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879047/
https://www.ncbi.nlm.nih.gov/pubmed/29484851
http://dx.doi.org/10.1111/1759-7714.12602
work_keys_str_mv AT linrongjia validationofthemandarinchineseversionoftheleicestercoughquestionnaireinnonsmallcelllungcancerpatientsaftersurgery
AT cheguowei validationofthemandarinchineseversionoftheleicestercoughquestionnaireinnonsmallcelllungcancerpatientsaftersurgery